n-MYC Amplification
Notes
**Note 1:** This SSDI is effective for diagnosis years 2023+
* For cases diagnosed 2018-2022, leave this SSDI blank
**Note 2:** Physician statement of n-MYC can be used to code this data item when no other information is available.
Metadata
SSDI
Code |
Description |
0 |
Not amplified |
1 |
Amplified |
2 |
Gain |
7 |
Test ordered, results not in chart |
8 |
Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of code 8 may result in an edit error) |
9 |
Not documented in medical record
Cannot be determined by pathologist
Not applicable (secondary to previous chemotherapy)
n-MYC not assessed or unknown if assessed |
<BLANK> |
N/A - Diagnosis year is prior to 2023 |
(1) American Society of Clinical Oncology © 2009, The International Neuroblastoma Risk Group (INRG) Classification System: AN INRG Task Force Report; published by American Society of Clinical Oncology, 2009